American International Group, Inc. Imara Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.78 - $9.04 $30,252 - $40,336	-4,462 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$8.18 - $23.98 $98 - $287	12 Added 0.27%	4,462 $38,000
Q4 2020 Feb 12, 2021	BUY	$15.81 - $29.0 $23,604 - $43,297	1,493 Added 50.49%	4,450 $98,000
Q3 2020 Nov 04, 2020	SELL	$18.75 - $28.58 $1,275 - $1,943	-68 Reduced 2.25%	2,957 $60,000
Q2 2020 Aug 12, 2020	BUY	$15.6 - $54.87 $47,190 - $165,981	3,025 New	3,025 $84,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.